When N‐glycosylation modification is absent, Fzd4 cannot mediate the Wnt/β‐catenin signalling pathway, which can inhibit the proliferation and migration of NSCLC and provide new targets and strategies for the treatment of NSCLC. This evidence concerns the gene FZD4 and non-small cell lung carcinoma.